A Pharmacokinetic (PK) Study of Natalizumab (Tysabri) at Steady State

Clinical trial NCT00744679 · COMPLETED

Trial details

NCT number: NCT00744679
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2008-11-01
Primary completion: 2008-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.